Molecular Biology, Biochemistry and Histology Core

分子生物学、生物化学和组织学核心

基本信息

  • 批准号：
    7750840
  • 负责人：
    SHYAMAL K. ROY
  • 金额：
    $ 19.12万
  • 依托单位：
    UNIVERSITY OF NEBRASKA MEDICAL CENTER
  • 依托单位国家：
    美国
  • 项目类别：
  • 财政年份：
    2009
  • 资助国家：
    美国
  • 起止时间：
    2009-07-01 至 2014-06-30
  • 项目状态：
    已结题

项目摘要

letter) who has an established protocol, and agreed to help us on this measurement. The core will collect and process the plasma as instructed and send the sample to Dr. Brosnihan for analysis. We believe that this is the most efficient way to obtain accurate measurements of Ang (1-7) without significant investment. The core will also provide support for the measurement of activities of NOS, SOD, NADPH oxidase and citrate synthase. The core has included Dr. Matthew C. Zimmerman as a co-investigator to help in reactive oxygen species (ROS) analysis because of his specific expertise in this area. The role of NO, Ang II and ROS in controlling cardiovascular dynamics has been adequately documented in all the listed projects. However, the underiying cellular and molecular mechanisms involving these factors are pooriy understood. This core is an integral component of the PPG and will provide service for all projects. Dr. Shaymal K. Roy will be actively involved, as the Director of the core unit, in designing experiments for various protocols, which use RIA, radioreceptor assay, immunohistochemistry. Western immunoblotting, and real time RT-PCR. He will make recommendations and improvements of protocols whenever needed. His expertise in these techniques is critical for the timely completion of the study and analysis of our results. The technical expertise and the equipment involved cannot be reproduced using facilities in any one of the laboratories of the investigators in the Program Project. Because almost all PPG investigators will use these techniques, a core unit will be ideal to meet their needs; thus eliminating major duplication in equipment and manpower. The core has been strengthened by the inclusion of Drs. Zimmerman and Brosnihan to address the cutting-edge questions in the proposed area of research. In fact, during the current funding period, the molecular and biochemical core has helped every investigator listed in the PPG in their research by analyzing samples as well as training post-doctoral fellows, graduate students and technicians of various molecular biology techniques critical for the success of each project. Therefore, Core C has proved its importance in the PPG and has become an indispensable and integral part of the project. The objectives of the present proposal cannot be reached without the assistance of Core C. 249 Zucker, Irving H. Progress Report The use of the Core has increased significantly during the past funding period because of the introduction of several new experimental approaches by investigators. Similar to the previous year, graduate students and post-doctoral trainees utilized the facility to the fullest extent. Because of the increased use of the immunofluorescence histochemistry, the Core has updated the fluorescence microscope with a new Dell computer, metal-halide fluorescence light source and a Leica bright field digital camera. The Core has been doing Western blots, gel-shift assays. Real-time RT-PCR, immunofluorescence, RIA of Ang II, and enzyme immunoassay of noradrenaline. The core has processed over 178 samples for Ang II RIA and 709 samples for NE EIA. In addition, we have processed 458 samples for RT-PCR and 137 samples for Western blots. Besides these, post-doctoral trainees and graduate students have processed their experimental samples themselves using the Core facilities. Altogether, a large number of samples were processed in the Core for various analytical purposes. We expect that the number will go up in future, and additional assays may need to be included as the research interests diversify. Personel in the Core have been using the real-time PCR on a regular basis. The use of commercial non-radioactive gel-shift kits for transcription factor analysis is being continued. Western blot analysis of various phosphorylated proteins has also been introduced in the Core. The Core processed brains of rabbits, mice and rats, rat muscle and carotid bodies, rabbit kidneys and neuronal cell lines during the previous funded period. We have processed dog, rabbit and rat plasma, rat urine and rabbit kidney and brain for norepinephrine analysis. Western blot analysis, gel shift and RT-PCR were used for angiotensin receptor and transcription factor analysis. The Core is working on establishing a chromatin immunoprecipitation (ChIP) assay to examine the transcriptional regulation of angiotensin receptors in tissues and cultured cells (see below). Western blot and RT-PCR analysis were also used for ACE and ACE2 protein and mRNA expression in rabbit brain tissues, ATiR, AT2R eNOS, nNOS, ETaR, ETbR and GAPDH proteins in rabbit kidneys, Gp91, nNOS, and eNOS proteins in rat muscle, ATiR, eNOS, nNOS, NMDA (Glutamate Receptor subtypes), and AMPA proteins in rat brain stem. We are analyzing NFkB phosphorylation using immunoblotting as well as IkB and IkK. As usual, the Core continuously trains post-doctoral and pre-doctoral students, and technicians involved in the PPG. Therefore, the core service is fulfilling its goal. The use of the fluorescence microscope and gel documentation system has again surpassed saturation because investigators are doing more studies that require these techniques. Consequently, we need to upgrade and service the equipment on a regular basis. Our future projection includes immunoblot analysis of Elk-1, Ikk, p38, ERK, PI3kinase and JNK proteins, and gel shift analysis of AP-1 complex. Besides, we will also do Real-time RT-PCR quantification of ATiR, NFkB/p65, and Elk-1 mRNA. The Core budget has been used to procure RT-PCR enzymes, primers and probes for real-time RT¿ PCR, antibodies, fluorophor-conjugated second antibodies, chemiluminescence substrate, and fine chemicals. The core purchased a small apparatus for electrophoresis and gel processing. The cost of repair and new purchase of pipettes will again be a part of next year's core budget. Overall, the molecular Core C is fulfilling its obligation to all members of the PPG and functions as an integral part of this program. Specific Methodologies A. Immunohistochemistry facility 1. Function This section of the Core provides technical and scientific support for investigators who need to use immunofluorescence histochemistry for localizing specific proteins in cells/tissues, which include neurons, brain sections, carotid bodies, etc. The Core has a Cryostat and paraffin sectioning facilities, and a research microscope equipped with an Q-imaging digital camera for incident-light image capture, a low-light sensitive Q- imaging Retiga fast 1294 camera for fluorescence image capture and appropriate software for image capture and analysis. The Core also provides appropriate secondary antibodies-flurophor conjugates for signal detection. 250 Zucker, Irving H. 2. Services available Mrs. Phyllis Anding, who has the expertise in immunohistochemistry and microscopic imaging, will carry out the procedures. She is certified in radioactive handling and environmental health. Her inclusion in the Core is critical to provide necessary services to the PPG investigators. She will also assist members of various investigators' laboratories in the above techniques. Dihydroethidium staining In order to evaluate the level of ROS in brain, muscle and carotid bodies, we will stain for the ROS marker Dihydroethidium (DHE). Unfixed fresh frozen sections (30 pm in thickness) will then be incubated with DHE (1x10"¿ M, Sigma, St. Louis, MO) and Hoechst 33258 (2x10'^ M, nuclear stain. Molecular Probes Inc., Eugene, OR), in PBS for 15 minutes in the dark at room temperature. Sections will be rinsed 3 times in PBS, coversliped and evaluated under epifluorescence in a Leica DMR research microscope equipped with an Optronics Magnafire digital camera (Optronics, Goleta, CA) and digitally photographed. Dr. Zimmerman will be consulted as necessary. General Immunofluorescence histochemistry protocol^ For all immunofluorescence histochemistry, tissues will be snap frozen in liquid nitrogen (LN2) and brought to cryostat temperature at -15¿C and sectioned at 10 pm thickness. Upon thawing on a slide warmer at 40¿C the sections will be fixed in 2% freshly prepared paraformaldehyde in PBS, pH 7.4 at 4¿C, rinsed thoroughly in PBS, and non-specific IgG binding sites blocked with 10% donkey serum in PBS containing 0.05% Tween 20 for 1 h at 4¿C. After removing the blocking solution, sections will be incubated overnight with antigen-specific primary antibodies at 4¿C, rinsed with PBS and the signal will be generated by incubating with the corresponding host-specific second antibody conjugated to Alexa 488 (green fluorescence), or Alexa 596 (red fluorescence) for uni- or multi-labeling. Nuclei will be stained with DAPI (blue) depending on the color of the antigen signal and viewed under an epifluorescence microscope. Periodically we will also use confocal microscopy for detail analysis of particular sections for specific experiments. UNMC imaging core facility contains two Zeiss multi-laser confocal microscopes, and service Is available for $40/h. For digital microphotography, the exposure time will be set using control sections, which have been incubated with either non-immune IgG or a particular primary antibody that has been preneutralized with 100-fold excess antigen, to eliminate any background fluorescence. The signal obtained after background correction will be considered specific and recorded digitally using a Q-imaging Retiga 1394 digital camera. In some instances, the intensity of the specific fluorescence will be quantified using NIH Image software. Immunohistochemistry protocols mentioned above will be carried out using antigen specific antibodies. For some proteins we will use antibodies, which have multispecies or monospecies specificity because the detection will involve endogenous enzyme proteins as well as proteins expressed by viral transgene. Monospecies specific antibody is particulariy important because it will allow us to detect (either by immunofluorescence or Western blotting) selectively human protein produced by the transgene at the injected areas without any contribution of the rat or rabbit protein. We have optimized the signal detection using these antibodies and been using during the previous funding period. Anticipated results, pitfalls and alternative approaches. Based on the experience during the current funding period, no major problems are anticipated. Unavailability of the pure antigens for immunoneutralization of the primary antibodies often presents a limitation to verify the specificity of the immunostaining. Although antibody host-specific IgG and no primary antibody controls sometime provide acceptable data, they are not always useful because the primary antibody, but not the preimmune IgG of the same species, often produce false positive staining. To circumvent this problem, we used tissues wherein some cells serve as negative control because they do not express the antigen of interest, thus helping us to judge the specificity of the staining. Second, we always verify the specificity of the antibody using Western blot analysis using positive and negative controls. 251 Zucker, Irving H. B. Enzyme assay, and protein electrophoresis and immunoblotting facility 1. Function This section of the core provides technical and scientific support for investigators who need to use enzyme photochemical and biochemical assays to detect NOS activity and protein levels, levels of ecNOS, ATiR and SOD proteins. The laboratory has a cryostat, incubator, microscopy and imaging facility, water bath, spectrophotometer for quantifying protein content, a complete system for polyacrylamide gel electrophoresis and Western immunoblotting, and UVP Bioimagerfor chemiluminescence signal detection. 2. Services available Mrs. Phyllis Anding will carry out these procedures. Mrs. Anding has been trained to perform these assays during the current funding period and has proven to be an essential member of the core. Without her help, timely service cannot be provided. The technologist will be adept at performing biochemical assay protocols as well as assisting members of various investigators' laboratories in the above techniques. SOD activitv assay SOD activitv: In-gel assay CuZnSOD and MnSOD activity will be measured using a native-gel activity stain as previously described^' ^. After separating cell lysates on a native gel using electrophoresis, SOD enzyme activity bands will be visualized by saturating the gel with 2.6 mM nitroblue tetrazolium (NBT), 28 mM riboflavin, and 28 mM tetramethylethylenediamine (TEMED) for 20 min in the dark and then illuminated under a fluorescent light until achromatic bands appeared. SOD activitv: Spitz/Oberlev spec assay'' Briefly, brains will be rapidly removed, flash frozen in dry ice, and sectioned to the anterior border of the lateral ventricles. Tissue surrounding the ventricles, including the lamina terminalis and SFO, will be dissected using a micropunch (1.24 mm diameter) and homogenized on ice with a Teflon pestle doused in 0.05 mol/L phosphate buffer (pH 7.8) with 1 mmol/L diethylenetriamine-pentaacetic acid (DETAPAC). Tissue protein content will be measured by the method of Lowry et al."* and increasing quantities (0 - 500|ig) will be placed in a solution containing 1 mmol/L DETAPAC, 1 unit of catalase, 5.6x10'^ mol/L nitro blue tetrazolium (NBT), 10"^ mol/L xanthine, 5 mmol/L NaCN, and 50 |xmol/L bathocuproine disulfonic acid. Xanthine oxidase will be added to initiate superoxide-mediated NBT reduction to blue formazan, and the rate of formation of colored product will be monitored spectrophotometrically at 560 nm^. The rate of NBT reduction in the absence of tissue will be used as the reference rate. Data will be expressed in units of SOD activity per milligram protein, where 1 unit is defined as the amount of enzyme needed to cause a 50% reduction in product formation using purified CuZnSOD in the absence of ON' as the standard^. NADPH Oxidase assay This will be done essentially as described by Ushio-Fukai et al.¿ Briefly, areas of brain from rats and rabbits, and carotid bodies from rabbits will be dissected, snap frozen in LN2, and homogenized in 0.05 M KPO4 buffer, pH 7.4 containing 10% glycerol and a protease inhibitor cocktail in a teflon-Dounce homogenizer. After measuring the protein content by micro BCA protein assay kit, the enzyme activity will be measured in a luninescence assay with 500 mM lucigenin as the electron acceptor and 100 mM NADPH as the substrate in a final volume of 0.9 ml. The reaction will be started by adding 100 ml of homogenate containing 50 mg protein, and photon emission will be measured every 15 s for 10-15 min in a luminometer available in the department of Biochemistry and Molecular biology at UNMC (7*^ floor of DRC building). The initial rate of enzyme activity will be calculated by linear regression. A buffer blank (<5% of the cell signal) will be subtracted from each reading prior to transformation of the data to nanomoles of O2, using a standard curve generated with xanthine/xanthine oxidase. Activity in a subset of samples will be measured in the presence of Tiron (20 mmol/l), a superoxide anion scavenger, to confirm that the signal is attributable to superoxide anion, and in the presence of diphenylene-iodonium (DPI, 10 jxmol/l), an NAD(P)H oxidase inhibitor, to confirm the activity is attributable to the enzyme. Citrate synthase assay This will be done according to the method described by Srere^ with slight modification. Breifly, tissues will be homogenized in 0.4 M KCI containing 10% glycerol, pH 7.4, and centrifuged at 23,000g for 30 min at 252 Zucker, Irving H. 4¿C. The supernatant will be separated, protein concentration determined and 5 ml of sample containing 20-30 mg protein mixed with 945 ml of a reaction mixture containing (final concentration) 0.1 mM dithiobis-nitro- benzoate (DTNB), 0.3 mM acetyl coA in deionized water. After taking readings at 412 nm for 3 min at 1 min intervals without the substrate, 50 ml of a 10 mM oxaloacetate will be added and the absorption will be followed for 3 more minutes at 1 min intervals at 37¿C. Enzyme activity will be expressed as nmol mercaptide formed/min/ mg protein. Western Immunoblotting Commercially available antigen specific mono or polyclonal antibodies will be used. Briefly, protein samples will be prepared by homogenizing tissues in 1x RIPA [PBS containing 1% NP-40, 0.5% deoxycholate and 0.1% SDS, pH 7.4]. The concentrations of protein in the samples will be determined by a Micro BCA protein assay kit (Pierce Chemical Company), and equal amounts of protein from all samples will be resolved in 10% polyacrylamide gel, transferred to PVDF membrane, blocked with 5% milk in Tris-buffered saline, pH 7.0 containing 0.05% Tween 20, and probed with antigen specific antibody. The signal will be generated using corresponding host-specific second antibody-peroxidase conjugate and WestFemto chemiluminescence substrate (Pierce). The light emanating from the specific protein band will be directly digitized using an UVP bioimager. The data will be presented as OD per mg protein. The same membrane will also be evaluated for b- tubulin protein to determine the specificity of changes in the levels of antigens, and for correcting any variability due to differences in sample loading. Electrophoretic Mobility Shift Assay (EMSA) ATiR expression is upregulated by the AP-1 and NFkB complexes. To determine the molecular mechanisms underiying the ATiR gene expression, we will examine the binding activity of transcription factors present in tissue samples using synthetic transcription factor consensus binding sites in EMSA. Two complementary oligos will be synthesized in the UNMC Eppley DNA Synthesis Core Facility at the University of Nebraska Medical Center. The oligomers will be labeled at the 3' end with biotin using the 3' End DNA Labeling Kit (Pierce), then annealed at room temperature to obtain double-stranded DNA. The binding reactions will contain 10 pg of nuclear extract protein, buffer (10 mM Tris, pH 7.5, 50 mM KCI, 5 mM MgCI2, 1 mM dithiothreitol, 0.05% Nonidet P-40, and 2.5% glycerol), 1 pg of poly(dl-dC), and 2 nM of biotin-labeled DNA. The reactions will be incubated at 23 "C for 20 min. The competition reactions will be performed by adding 100-fold excess unlabeled double stranded AP-1 or NFkB consensus oligonucleotides to the reaction mixture. In antibody supershift assays, incubation will be performed in the absence or presence of 2 pg of anti- c-Jun antibody (Santa Cruz Biotechnology) added to the reaction mixture. The reactions will then be electrophoresed on a 5% native polyacrylamide gel in 0.5X TBE at 100 V for 1 h in 0.5X TBE buffer. The reactions will be transferred to a nylon membrane. The biotin-labeled DNA will be detected with a LightShift chemiluminescent electrophoretic mobility shift assay kit (Pierce). The bands on the membrane will be digitized and analyzed using UVP Biolmaging Systems. We have used this assay in previous experiments as indicated in Project 1¿'^. Similar protocols will be used for other transcription factors. Chromatin Immunoprecipitation (ChIP) Assay In order to determine precise binding of a give transcription factor to the promoter regions of specific genes we will use a ChIP assay. Our test material will include Cath.a and NG-108 cells as well as tissue punch biopsies take from various brain areas such as the RVLM, NTS and PVN in our animal models (rat, mouse, rabbit). ChIP would be done after appropriate experimental protocols, using the ChIP assay kit from Upstate (Lake Placid, NY) as per the manufacturer's instructions. Briefly, after appropriate treatment, cells will be washed in cold PBS and crosslinked by adding formaldehyde to a final concentration of 1%. Tissue samples will first be homogenized and then treated with formaldehyde. Nuclear extraction after formaldehyde fixation would be done in lysis buffer (50 mM Tris [pH 8,0], 2 mM EDTA, 0.1% Nonidet P-40, and 10% glycerol) supplemented with protease inhibitors. Chromatin will be sheared by sonication, centrifuged, and pre-cleared for 3 h with salmon sperm-saturated protein A/G- agarose (ssProtein A/G). Immunoprecipitation would be carried out overnight at 4¿C using 5 pi of anti- p65 253 Zucker, Irving H. antibody (Cell Signaling) and the immune complexes collected with ssProtein A/G for 30 min and washed three times in washing buffer and once in 0.5 M LiCI, followed by three washes with TE buffer. Immune complexes would be extracted 3 times with 100 pi of extraction buffer and DNA cross-links reverted by heating for 8 h at 65¿C. After proteinase K (100 pg for 2 h) digestion, DNA would be extracted with phenol/chloroform and precipitated in ethanol. PCR would be done with total DNA (1 pi, input control) and immunoprecipitated DNA (2 pi) using the appropriate species-specific and promoter-specific primers. C. RNA preparation and RT-PCR facility 1. Function This section of the Core provides technical and scientific support for investigators who will quantify the relative steady-state levels of mRNA in tissues. The Core laboratory has a microfuge, a thermocycler, water baths, areas for RNA extraction, agarose gel electrophoresis, capillary blotting. Southern and Northern hybridization oven, and a dedicated area for RT-PCR amplification of mRNA. We also have a MJ Research Opticon 4 thermocycler for real time quantification of mRNA levels. 2. Service available The overall function of the facility will be supervised by Dr. Shaymal K. Roy, who will make recommendations about relevant protocols to suit the investigators' needs. Phyllis Anding will be responsible for RNA extraction and real-time RT-PCR evaluation of various gene transcripts. Mrs. Anding has been fully involved in this capacity during the current funding period, and is well trained to undertake the task. Her inclusion in the Core is essential for timely progress of the study. She will also assist members of various investigators' laboratories in the above techniques. Extraction of RNA from tissue samples Total RNA will be extracted from various areas of the rat and rabbit and mouse brains, and rabbit carotid bodies using RNAeasy mini kit (Qiagen, CA) according to the manufacturer's protocol. In brief, tissues frozen in liquid N2 will be thawed directly in the lysis buffer at room temperature and homogenized using an Omni homogenizer. After 5 min centrifugation to remove undissolved debris, the supernatant will be mixed with 70% ethanol and loaded on to RNA binding columns. The columns will be centrifuged, washed with appropriate buffer and the RNA eluted in small volume of RNase-free water, and quantified spectrophotometrically at 260/280 nm. The RNAeasy protocol is based on chaotropic salt, which allows very clean RNA preparation in a very short time and without generating any phenol by-product. Because the core has been processing an enormous number of samples for RNA preparation, using method that can be done quickly without any compromise in the RNA quality or yield is essential. Quantification of NOS. NADPH oxidase. SOD and AT<R mRNA levels in tissue samples We have established probe-based real-time RT-PCR protocols for quantifying rabbit and rat nNOS, ecNOS, actin and GAPDH mRNA. The cDNA has been generated using the iScript cDNA Sysnthesis Kit (Bio¿ Rad). Gene Specific primers and probes have been synthesized in the UNMC Eppley Cancer Center DNA synthesis Core Facility. Gene-specific probes have been labeled with FAM at the 5' site and with Blackhole at the 3' site to add specificity and sensitivity. Real-time PCR is performed by using HotStarTaq DNA polymerase (Qiagen) on CHR0M04 Continuous Fluorescence Detector (Bio-Rad). The amount of specific mRNA is normalized against the actin or GAPGH mRNA levels, which are used as house-keeping genes for our tissues, to correct for any procedural variability and to validate the specificity in gene expression. The protocols for nNOS, ecNOS, and actin PCR are as follows: 15 min (¿ 95¿C, 30 s @ 94''C, 30 s (@ 55¿C followed by a plate reading for 40 cycles. The protocols for SOD-1 are as follows: 15 min @ 95¿C, 30 s (g 94¿C, 30 s (g 60¿C followed by a plate reading for 30 cycles. The protocols for ATI PCR are as follows: 15 min @ 95¿C, 30 s (g 94.¿C, 30 s @ 56 ¿C followed by a plate reading for 30 cycles. The quantification of mRNA is done from the (q)t using the protocol supplied by the manufacturer. We use similar protocols for amplifying rabbit and rat ATI mRNA. Rat and rabbit gene-specific PCR primers are either designed based on the concensus sequences after multispecies alignment and comparison or adopted from published sequences. Therefore, GeneBank accession numbers have been provided only for adopted sequences. Primer sequences for rat ATiR are derived from Laukkanen et al.^¿ and Zhou et al.^\ respectively, and from Yang et al.^^. 254 Zucker, Irving H. The accession numbers of the primer sets for various gene products are presented below mRNA Rabbit nNOS (designed) Rat nNOS (designed) Rat nNOS(Accession: NM 052799) Rabbit ecNOS (designed) Rabbit actin (designed) Rat actin (designed) Rat actin (Accession: NM 031144): Rat ATi (Accession: NM 032009) Rabbit ATiR Rat AT2 (Accession: NM 012494) Rat NRI (Accession: NM 017010): Rat NR2B (Accession: NM 012574): Rat AMPAA (Accession: NM 031608) Rat GABAA (Accession: NM012956) Rat GAD (Accession: NM012563) Rat p47 (Accession: AF260779), gp91 (Accession: AF298656) ACE2 (Accession: NM030985) Mas (Accession: NM001 002288) AR Alpha 1A (Accession: NM017191 AR Alpha ID (Accession: NM 024483 RPL 19 (Accession: NM 031 103 Because quantitative PCR protocols for these gene transcripts have already been established in the Core, we do not expect any major problems in their use. The control for DNA contamination will be: omission of reverse transcriptase during RT reaction and the control for PCR product synthesis will be RT with no RNA. The specificity of gene expression will be verified by amplifying actin as a house keeping gene, because no major alteration in the levels of actin transcripts in nerve cells has been observed. C. Radioimmunoassay facility 1. Function This section of the Core provides technical and scientific support for investigators who will determine plasma levels of Ang II, Ang (1-7) and norepinephrine (NE). The facility has a refrigerated centrifuge, temperature controlled shaking water baths, scintillation counter and gamma counter. A separate computer station is available for data analysis. In the coming year we plan to procure an HPLC with electrochemical detector for measuring the levels of NE. 2. Service available Mrs. Phyllis Anding will carry out Ang II RIA and NE assays, whereas Dr. Brosnihan will carry out the Ang (1-7) assay. Projects l-IV will use the Ang II and NE RIA service, while Projects l-lll will use the angiotensin (1-7) assay service. Angiotensin II RIA The protocol has been optimized and verified by spiking plasma samples with known and unknown amounts of pure Ang II. In the past, Dr. lan Reid (University of California, San Francisco) assayed Ang II for the PPG; however, he has since retired and provided us with the antibody for carrying out the assay in the 255 Zucker, Irving H. Core facility, which we have done successfully. The protocol for Ang II extraction from plasma samples is essentially similar to that described by Raff et al.^^; however, we have modified the protocols for final sample preparation and the assay, which has resulted in a significant improvement of the assay. The sensitivity of the assay is 2 pg/tube. Aldosterone RIA Aldosterone will be measured in plasma using a commercially available RIA kit (IBL, Inc.). 200 pi of sample are necessary for each assay. Angiotensin (1-7) RIA Blood will be collected in a pre-chilled EDTA tube containing a cocktail of protease inhibitors including 0.44 mM 1,20 ortho-phenanthroline monohydrate (Sigma, St. Louis MO.), 0.12 mM pepstatin (Peninsula Labs, Belmont CA), and 1 mM Na p-hydroxymercuribenzoate (Sigma, St. Louis MO), centrifuged to remove the blood cells and the plasma will be stored at -80¿C until assayed. Plasma will be extracted using Sep-Pak columns activated with 5 ml sequential washes of a mixture of ethanol:water:4% acetic acid (83:13:4), methanol, ultra pure water, and 4% acetic acid. After applying samples, the column will be washed with ultrapure water and acetone and eluted with 3.5 ml washes of a mixture of ethanol:water:4% acetic acid. The sample will be eluted, reconstituted and radioimmunoassayed. For Ang-(1-7), a TRIS buffer with 0.1% BSA will be used. Recoveries of radiolabeled angiotensin added to the sample and followed through the extraction are expected to be 92% (n=23). Samples will be corrected for recoveries. Ang-(1-7) will be measured in Dr. Brosnihan's laboratory using the antibody previously described^''' ^^. The minimum detectable level of the assay is 1.39 fmol (2.5 pg)/tube for Ang-(1-7). Values at or below the minimum detectable level (MDL) of the assay will be arbitrarily assigned for statistical analysis. The routine intra-assay coefficient of variation is 8% for Ang-(1-7). Ang-(1-7) antibody does not cross react with Ang I or Ang II. D. Reactive oxygen species (ROS) detection facility 1. Function This section of the core provides technical and scientific support for investigators who will determine ROS production in tissues (Projects I, III and IV). 2. Service available Dr. Matthew Zimmerman, who will make recommendations about relevant protocols to suit the investigators' needs, will supervise the overall functioning of the facility. A technologist will be adept at assisting members of various investigators' laboratories in the above techniques. EPR measurement of reactive oxygen species (ROS) and reactive nitrogen species fRNS): ROS and RNS in cultured cells as well as in blood and tissue samples from experimental animals will be measured by electron paramagnetic resonance (EPR). EPR is one of the most sensitive and definitive methods for measuring short-lived free radical intermediates both in vitro and in vivd'^. Traditionally, EPR and nitrone compounds called "spin traps" have been used to detect free radicals in in vitro systems. However, the nitrone spin trap radical adducts can be reduced by flavins, thiols, and ascorbate when exposed to cells and tissues resulting in non-detectable species^^. Considering we propose to measure radicals in biological samples, we will primarily use a second class of EPR-detectable, radical-sensitive compounds, often referred to as "spin probes", called cyclic hydroxylamines. More specifically, to measure total ROS and 02*" levels, we will use the spin probe 1-hydroxy-3-methoxycarbonyl-2, 2, 5, 5-tetramethylpyrrolidine (CMH) and to measure peroxynitrite we will use 1-hydroxy-3-carboxypyrrolidine (CPH). To measure nitric oxide levels we will use the colloid Fe- diethyldithiocarbamate (Fe(DETC)2)^^. All EPR measurements will be performed with a Bruker E-scan EPR spectrophotometer (Bruker BioSpin GmbH, Rheinstetten/Karisruhe, Germany). The spin probes will be obtained from from Noxygen Science Transfer and Diagnostics (Elzach, Germany) and all other reagents will be purchased from Sigma-Aldrich unless otherwise specified. These measurements will be carried out in the laboratory of our co-investigator, Dr. Matthew C. Zimmerman although it we consider this a Core function. 256 Zucker, Irving H. Sample preparation for EPR studies: For cultured cells, media will be removed and cells will be rinsed with chilled Krebs-HEPES buffer (KHB) containing the metal chelators DETC (2 pM) and deferoxamine (DF, 50 pM). Cells will then be incubated with this buffer containing one of the spin probes listed above for 30-60 minutes at 37¿C. For tissue samples, isolated carotid body, muscle, or brain tissue punches (medullary or hypothalamic regions) will be minced and placed into a 96-well tissue culture plate containing KHB with DF and DETC. Tissue pieces will then be washed twice with the buffer to remove any trace contamination. Subsequently, tissues will be incubated at 37¿C with specific spin probes for 30-60 minutes. Measurement of total ROS levels: After incubating cultured cells or tissue samples with CMH (200 pM) for 30 minutes, aliquots of the incubated probe media will be placed in 50 pi glass capillary tubes (Noxygen Science Transfer and Diagnostics, Elzach, Germany) and total ROS levels will be determined using the following EPR settings: sweep width 110.020G; microwave frequency 9.453 GHz; microwave power I 1.0157 mW; modulation amplitude 6.01 G; [¿10*6] conversion time 20.480 ms; time constant 81.92 4- ms; receiver gain 3.17 ¿*¿¿^. -T 3- 3 rB Measurement of specific ROS and RNS ¿a levels: Considering spin probes CMH and CPH can react with different radical species to yield the same ¿f-1 (a) Sham product, and therefore the same EPR spectrum, it is 0. ,j Ul "*- g - 2.00279 (b)MI necessary to perform experiments in the absence (c)Ml + ATS and presence of specific inhibitors of the ROS and RNS in question. For example, to specifically 3372.0 3373.0 3374.0 3375.0 3376.0 3377.0 3378.0 3379.0 3360.0 measure O2*" levels, cultured cells, tissue, or whole Figure 1. EPR spectra of superoxide production in the blood will be incubated at 37''C with PEG-SOD (50 hypothalamus of sham, Ml and Ml mouse treated with U/ml) for 60 minutes followed by incubation with atorvastatin. Right hand top panel shows the group data. CMH (200pM). Aliquots of the incubated probe media will be placed in 50 pi glass capillary tubes for determination of total O2*" levels. By scavenging O2'", PEG-SOD competitively inhibits the CMH-O2" reaction. Since PEG-SOD is cell permeable, it inhibits the CMH-02"" interaction both intracellularly and extracellulariy, thus allowing for the accurate, specific measurement of 02"'. The EPR spectra obtained from incubation with PEG-SOD and CMH will be subtracted from the spectra obtained from incubation with CMH only. In a similar manner, urate will be used to scavenge peroxynitrite and the urate-inhibitable CPH spectrum will be measured to determine the levels of peroxynitrite in our samples. Finally, to measure nitric oxide levels, EPR spectrum will be obtained from cultured cells or tissue samples incubated with the nitric oxide-specific spin trap Fe(DETC)2. Although we believe that EPR is the gold standard for quantitatively measuring specific ROS and RNS both in vitro and in vivo, we understand the importance of corroborating data obtained from such studies. Importantly, we have significant experience with other techniques used to measure these reactive species, such as lucigenin-enhanced chemiluminescence (ECL) (TD-20/20 luminometer; Turner Designs; Sunnyvale, CA) and oxidant-sensitive fluorogenic probes (dihydroethidium (DHE) fluorescence). We propose to use these techniques as alternative methods. Figure 1 shows representative EPR tracings from rats with CHF and mice with CHF treated with atorvastatin. New Techniques and future directions Among the new techniques, the Core has included immunofluorescence histochemistry, direct digitization of Western blot signal, which eliminated the problems associated with film densitometry, cell culture to optimize the proper dosage of adenovirus-gene constructs, and probe-based Real-Time RT-PCR for true quantification of the mRNA levels in samples. The Core will introduce an HPLC-based electro chemical detection of NE in the plasma, urine and tissues; 257 Zucker, Irving H. It should be pointed out that while Mrs. Phyllis Anding will carry out many of the Core procedures she will not be the only individual participating in Core functions. Mrs Yu Li from Dr. Zucker'

项目成果

期刊论文数量（0）
专著数量（0）
科研奖励数量（0）
会议论文数量（0）
专利数量（0）

数据更新时间：{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI：
    {{ item.doi }}
  • 发表时间：
    {{ item.publish_year }}
  • 期刊：
    {{ item.journal_name }}
  • 影响因子：
    {{ item.factor }}
  • 作者：
    {{ item.authors }}
  • 通讯作者：
    {{ item.author }}

数据更新时间：{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者：
    {{ item.author }}

数据更新时间：{{ monograph.updateTime }}

{{ item.title }}
  • 作者：
    {{ item.author }}

数据更新时间：{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者：
    {{ item.author }}

数据更新时间：{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者：
    {{ item.author }}

数据更新时间：{{ patent.updateTime }}

SHYAMAL K. ROY其他文献

SHYAMAL K. ROY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI：
    {{ item.doi }}
  • 发表时间：
    {{ item.publish_year }}
  • 期刊：
    {{ item.journal_name }}
  • 影响因子：
    {{ item.factor }}
  • 作者：
    {{ item.authors }}
  • 通讯作者：
    {{ item.author }}

{{ truncateString('SHYAMAL K. ROY', 18)}}的其他基金

Novel regulation of early follicle formation
早期卵泡形成的新调控
  • 批准号：
    10207699
  • 财政年份：
    2019
  • 资助金额：
    $ 19.12万
  • 项目类别：
Novel regulation of early follicle formation
早期卵泡形成的新调控
  • 批准号：
    10438707
  • 财政年份：
    2019
  • 资助金额：
    $ 19.12万
  • 项目类别：
Novel regulation of early follicle formation
早期卵泡形成的新调控
  • 批准号：
    10669562
  • 财政年份：
    2019
  • 资助金额：
    $ 19.12万
  • 项目类别：
CORE--MOLECULAR BIOLOGY, BIOCHEMISTRY & HISTOLOGY
核心--分子生物学、生物化学
  • 批准号：
    6928293
  • 财政年份：
    2004
  • 资助金额：
    $ 19.12万
  • 项目类别：
CORE--MOLECULAR BIOLOGY, BIOCHEMISTRY AND HISTOLOGY
核心--分子生物学、生物化学和组织学
  • 批准号：
    6606560
  • 财政年份：
    2002
  • 资助金额：
    $ 19.12万
  • 项目类别：
FOLLICULAR MORPHOGENESIS DURING PERINATAL DEVELOPMENT
围产期发育期间的卵泡形态发生
  • 批准号：
    6637057
  • 财政年份：
    2001
  • 资助金额：
    $ 19.12万
  • 项目类别：
FOLLICULAR MORPHOGENESIS DURING PERINATAL DEVELOPMENT
围产期发育期间的卵泡形态发生
  • 批准号：
    6740919
  • 财政年份：
    2001
  • 资助金额：
    $ 19.12万
  • 项目类别：
CORE--MOLECULAR BIOLOGY, BIOCHEMISTRY AND HISTOLOGY
核心--分子生物学、生物化学和组织学
  • 批准号：
    6457669
  • 财政年份：
    2001
  • 资助金额：
    $ 19.12万
  • 项目类别：
Follicular morphogenesis during perinatal development
围产期发育过程中的卵泡形态发生
  • 批准号：
    7367993
  • 财政年份：
    2001
  • 资助金额：
    $ 19.12万
  • 项目类别：
Follicular morphogenesis during perinatal development
围产期发育过程中的卵泡形态发生
  • 批准号：
    8091316
  • 财政年份：
    2001
  • 资助金额：
    $ 19.12万
  • 项目类别：

相似海外基金

Lung developmental defects caused by type I collagen mutations in mouse models of osteogenesis imperfecta
成骨不全小鼠模型中 I 型胶原蛋白突变引起的肺发育缺陷
  • 批准号：
    10735577
  • 财政年份：
    2023
  • 资助金额：
    $ 19.12万
  • 项目类别：
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells
桥粒斑蛋白对肺泡2型细胞肺纤维化的遗传贡献机制研究
  • 批准号：
    10736228
  • 财政年份：
    2023
  • 资助金额：
    $ 19.12万
  • 项目类别：
Defining the cellular dynamics that orchestrate alveolar epithelial cell repair behaviors in live mammal
定义协调活体哺乳动物肺泡上皮细胞修复行为的细胞动力学
  • 批准号：
    10556676
  • 财政年份：
    2023
  • 资助金额：
    $ 19.12万
  • 项目类别：
PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology Study
PNA5：一种新型 Mas 受体激动剂，用于治疗有血管性痴呆和阿尔茨海默氏病相关痴呆风险的患者的认知障碍：FDA 要求的毒理学研究
  • 批准号：
    10705874
  • 财政年份：
    2023
  • 资助金额：
    $ 19.12万
  • 项目类别：
DLL4 in the Developing Lung and Bronchopulmonary Dysplasia (BPD)
DLL4 在发育中的肺和支气管肺发育不良 (BPD) 中的作用
  • 批准号：
    10584811
  • 财政年份：
    2023
  • 资助金额：
    $ 19.12万
  • 项目类别：
{{ showInfoDetail.title }}

作者：{{ showInfoDetail.author }}

知道了